Abstract
Hypoxic pulmonary vasoconstriction (HPV) is an adaptive mechanism that in the face of localised alveolar hypoxia diverts blood away from poorly ventilated regions of the lung, thereby preserving ventilation/perfusion matching. HPV has been recognised for many years, but although the underlying mechanisms are known to reside within the arteries themselves, their precise nature remains unclear. There is a growing consensus that mitochondria act as the oxygen sensor, and that Ca2+ release from ryanodine-sensitive stores and Rho kinase-mediated Ca2+ sensitisation are critical for sustained vasoconstriction, though Ca2+ entry via both voltage-dependent and/or -independent pathways has also been implicated. There is, however, controversy regarding the signalling pathways that link the oxygen sensor to its effectors, with three main hypotheses. The AMP-activated protein kinase (AMPK) hypothesis proposes that hypoxic inhibition of mitochondrial function increases the AMP/ATP ratio and thus activates AMPK, which in turn mediates cADPR-dependent mobilisation of ryanodine-sensitive sarcoplasmic reticulum Ca2+ stores. In contrast the two other hypotheses invoke redox signalling, albeit in mutually incompatible ways. The Redox hypothesis proposes that hypoxia suppresses mitochondrial generation of reactive oxygen species (ROS) and causes the cytosol to become more reduced, with subsequent inhibition of KV channels, depolarisation and voltage-dependent Ca2+ entry. In direct contrast the ROS hypothesis proposes that hypoxia causes an apparently paradoxical increase in mitochondrial ROS generation, and it is this increase in ROS that acts as the signalling moiety. In this article we describe our current understanding of HPV, and evidence in support of these models of oxygen-sensing.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aaronson PI, Robertson TP, Knock GA, Becker S, Lewis TH, Snetkov V & Ward JP. (2006). Hypoxic pulmonary vasoconstriction: mechanisms and controversies. J Physiol 570, 53–58.
Chandel NS & Schumacker PT. (2000). Cellular oxygen sensing by mitochondria: old questions, new insight. J Appl Physiol 88, 1880–1889.
Dipp M & Evans AM. (2001). Cyclic ADP-ribose is the primary trigger for hypoxic pulmonary vasoconstriction in the rat lung in situ. Circ Res 89, 77–83.
Dipp M, Nye PC & Evans AM. (2001). Hypoxic release of calcium from the sarcoplasmic reticulum of pulmonary artery smooth muscle. Am J Physiol Lung Cell Mol Physiol 281, L318–325.
Duchen MR & Biscoe TJ. (1992). Mitochondrial function in type I cells isolated from rabbit arterial chemoreceptors. J Physiol 450, 13–31.
Evans AM. (2006). AMP-activated protein kinase and the regulation of Ca2+ signalling in O2-sensing cells. J Physiol 574, 113–123.
Evans AM, Mustard KJ, Wyatt CN, Peers C, Dipp M, Kumar P, Kinnear NP & Hardie DG. (2005). Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells? J Biol Chem 280, 41504–41511.
Hambraeus-Jonzon K, Bindslev L, Mellgard AJ & Hedenstierna G. (1997). Hypoxic pulmonary vasoconstriction in human lungs. A stimulus-response study. Anesthesiology 86, 308–315.
Leach RM, Hill HM, Snetkov VA, Robertson TP & Ward JP. (2001). Divergent roles of glycolysis and the mitochondrial electron transport chain in hypoxic pulmonary vasoconstriction of the rat: identity of the hypoxic sensor. J Physiol 536, 211–224.
Leach RM, Robertson TP, Twort CH & Ward JP. (1994). Hypoxic vasoconstriction in rat pulmonary and mesenteric arteries. Am J Physiol 266, L223–231.
Michelakis ED, Hampl V, Nsair A, Wu X, Harry G, Haromy A, Gurtu R & Archer SL. (2002). Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ Res 90, 1307–1315.
Moudgil R, Michelakis ED & Archer SL. (2005). Hypoxic pulmonary vasoconstriction. J Appl Physiol 98, 390–403.
Ng LC, Wilson SM & Hume JR. (2005). Mobilization of SR stores by hypoxia leads to consequent activation of capacitative Ca2+ entry in isolated canine pulmonary arterial smooth muscle cells. J Physiol 563, 409–419.
Post J, Weir EK, Archer SL & Hume J. (1993). Redox regulation of K+ channels and hypoxic pulmonary vasoconstriction. In Ion Flux in Pulmonary Vascular Control, ed. Weir EK, Hume J & Reeves J. Futura Publishing Company, New York.
Quintero M, Colombo SL, Godfrey A & Moncada S. (2006). Mitochondria as signaling organelles in the vascular endothelium. Proc Natl Acad Sci U S A 103, 5379–5384.
Robertson T, Hashmi-Hill M, Vandenplas ML & Lewis SJ. (2005). Endothelium-dependent activation of Rho-kinase during hypoxic pulmonary vasoconstriction in rat intrapulmonary arteries. FASEB J 19, A1277.
Robertson TP, Aaronson PI & Ward JP. (1995). Hypoxic vasoconstriction and intracellular Ca2+ in pulmonary arteries: evidence for PKC-independent Ca2+ sensitization. Am J Physiol 268, H301–307.
Robertson TP, Dipp M, Ward JP, Aaronson PI & Evans AM. (2000a). Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat. Br J Pharmacol 131, 5–9.
Robertson TP, Hague D, Aaronson PI & Ward JP. (2000b). Voltage-independent calcium entry in hypoxic pulmonary vasoconstriction of intrapulmonary arteries of the rat. J Physiol 525 Pt 3, 669–680.
Robertson TP, Ward JP & Aaronson PI. (2001). Hypoxia induces the release of a pulmonary-selective, Ca2+-sensitising, vasoconstrictor from the perfused rat lung. Cardiovasc Res 50, 145–150.
Turrens JF. (2003). Mitochondrial formation of reactive oxygen species. J Physiol 552, 335–344.
Wang QS, Zheng YM, Dong L, Ho YS, Guo Z & Wang YX. (2007). Role of mitochondrial reactive oxygen species in hypoxia-dependent increase in intracellular calcium in pulmonary artery myocytes. Free Radical Biology & Medicine 42, 642–653.
Wang Z, Jin N, Ganguli S, Swartz DR, Li L & Rhoades RA. (2001). Rho-kinase activation is involved in hypoxia-induced pulmonary vasoconstriction. Am J Respir Cell Mol Biol 25, 628–635.
Ward JP. (2008). Oxygen sensors in context. Biochim Biophys Acta 1777, 1–14.
Ward JP, Snetkov VA & Aaronson PI. (2004). Calcium, mitochondria and oxygen sensing in the pulmonary circulation. Cell Calcium 36, 209–220.
Waypa GB, Chandel NS & Schumacker PT. (2001). Model for hypoxic pulmonary vasoconstriction involving mitochondrial oxygen sensing. Circ Res 88, 1259–1266.
Waypa GB, Guzy R, Mungai PT, Mack MM, Marks JD, Roe MW & Schumacker PT. (2006). Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circ Res 99, 970–978.
Waypa GB & Schumacker PT. (2005). Hypoxic pulmonary vasoconstriction: redox events in oxygen sensing. J Appl Physiol 98, 404–414.
Weir EK & Archer SL. (1995). The mechanism of acute hypoxic pulmonary vasoconstriction: the tale of two channels. FASEB J 9, 183–189.
Weissmann N, Tadic A, Hanze J, Rose F, Winterhalder S, Nollen M, Schermuly RT, Ghofrani HA, Seeger W & Grimminger F. (2000). Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase- derived H2O2? Am J Physiol Lung Cell Mol Physiol 279, L683–690.
Wilson HL, Dipp M, Thomas JM, Lad C, Galione A & Evans AM. (2001). ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase act as a redox sensor. A primary role for cyclic ADP-ribose in hypoxic pulmonary vasoconstriction. J Biol Chem 276, 11180–11188.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Mark Evans, A., Ward, J.P. (2009). Hypoxic Pulmonary Vasoconstriction – Invited Article . In: Gonzalez, C., Nurse, C.A., Peers, C. (eds) Arterial Chemoreceptors. Advances in Experimental Medicine and Biology, vol 648. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2259-2_40
Download citation
DOI: https://doi.org/10.1007/978-90-481-2259-2_40
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2258-5
Online ISBN: 978-90-481-2259-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)